{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:12:15Z","timestamp":1772190735286,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":2413,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"ISTH Presidential Fund"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1111\/jth.13257","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T21:40:44Z","timestamp":1453153244000},"page":"675-684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antiphospholipid antibodies and the risk of severe and non\u2010severe pre\u2010eclampsia: the NOHA case\u2010control study"],"prefix":"10.1016","volume":"14","author":[{"given":"T.","family":"Marchetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"de Moerloose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Gris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13257_bb0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"10.1111\/jth.13257_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1081\/PRG-200030301","article-title":"Maternal deaths associated with hypertensive disorders of pregnancy: a population\u2010based study","volume":"23","author":"Moodley","year":"2004","journal-title":"Hypertens Pregnancy"},{"key":"10.1111\/jth.13257_bb0020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/HYPERTENSIONAHA.107.107565","article-title":"Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study","volume":"51","author":"Chappell","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/jth.13257_bb0025","doi-asserted-by":"crossref","first-page":"159124","DOI":"10.1155\/2013\/159124","article-title":"Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications","volume":"2013","author":"Marchetti","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1111\/jth.13257_bb0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.20452\/pamw.2025","article-title":"Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?","volume":"123","author":"Marchetti","year":"2013","journal-title":"Pol Arch Med Wewn"},{"key":"10.1111\/jth.13257_bb0035","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"beta(2) \u2010Glycoprotein I: evolution, structure and function","volume":"9","author":"de Groot","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1751-553X.2012.01414.x","article-title":"Recent developments in our understanding of the antiphospholipid syndrome","volume":"34","author":"De Groot","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.13257_bb0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2393-9-11","article-title":"Elevated antiphospholipid antibody titers and adverse pregnancy outcomes: analysis of a population\u2010based hospital dataset","volume":"9","author":"Nodler","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1111\/jth.13257_bb0050","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/acr.22066","article-title":"Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"65","author":"Andreoli","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/jth.13257_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1182\/blood-2012-03-378646","article-title":"The significance of autoantibodies against beta2\u2010glycoprotein I","volume":"120","author":"de Groot","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13257_bb0060","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1538-7836.2009.03588.x","article-title":"The association between circulating antibodies against domain I of beta2\u2010glycoprotein I and thrombosis: an international multicenter study","volume":"7","author":"de Laat","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2012.05.006","article-title":"Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome","volume":"12","author":"Mahler","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1111\/jth.13257_bb0070","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/jth.12865","article-title":"Padayattil Jose S. Antibodies to Domain 1 (Dm1) of beta2\u2010Glycoprotein 1 (beta2GP1) correctly classify patients at risk in Antiphospholipid Syndrome (APS)","volume":"13","author":"Pengo","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0075","doi-asserted-by":"crossref","first-page":"724592","DOI":"10.1155\/2013\/724592","article-title":"Detection of antiphosphatidylserine\/prothrombin antibodies and their potential diagnostic value","volume":"2013","author":"Zigon","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1111\/jth.13257_bb0080","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1515\/cclm-2014-1129","article-title":"Relationship between antiphosphatidylserine\/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome","volume":"53","author":"Hoxha","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.13257_bb0085","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2005.01581.x","article-title":"Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case\u2010control \u2018NOHA first\u2019 study","volume":"3","author":"Lissalde\u2010Lavigne","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0090","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0038-1649988","article-title":"Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants\/Antiphospholipid Antibodies of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","article-title":"Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis","volume":"7","author":"Pengo","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0100","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/jth.12732","article-title":"Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti\u2010beta2 glycoprotein\u20101 antibodies","volume":"12","author":"Fontana","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0002-9378(96)70162-X","article-title":"Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome","volume":"175","author":"Audibert","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jth.13257_bb0110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1469-0705.1994.04060457.x","article-title":"Estimation of gestational age by transvaginal sonographic measurement of greatest embryonic length in dated human embryos","volume":"4","author":"Wisser","year":"1994","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1111\/jth.13257_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/uog.2733","article-title":"French fetal biometry: reference equations and comparison with other charts","volume":"28","author":"Salomon","year":"2006","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1111\/jth.13257_bb0120","doi-asserted-by":"crossref","unstructured":"ACOG technical bulletin. Hypertension in pregnancy. Number 219\u2013January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996; 53: 175\u201083.","DOI":"10.1016\/S0020-7292(96)90112-5"},{"key":"10.1111\/jth.13257_bb0125","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/oxfordjournals.aje.a009400","article-title":"Comparison of risk factors for preeclampsia and gestational hypertension in a population\u2010based cohort study","volume":"147","author":"Ros","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jth.13257_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/asheducation.V2012.1.455.3806865","article-title":"Dos and don'ts in diagnosing antiphospholipid syndrome","volume":"2012","author":"Rand","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/jth.13257_bb0135","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.18295\/2075-0528.1622","article-title":"Fluctuation in the levels of immunoglobulin M and Immunoglobulin G Antibodies for Cardiolipin and beta2\u2010Glycoprotein among healthy pregnant women","volume":"14","author":"Al\u2010Balushi","year":"2014","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1111\/jth.13257_bb0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1538-7836.2010.03747.x","article-title":"Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies","volume":"8","author":"Chauleur","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13257_bb0145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood-2013-08-522623","article-title":"Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH\u2010APS observational study","volume":"123","author":"Bouvier","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13257_bb0150","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.13257_bb0155","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2013.09.010","article-title":"Placental pathology suggesting that preeclampsia is more than one disease","volume":"210","author":"Nelson","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/jth.13257_bb0160","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/aje\/kwt189","article-title":"Associations of personal and family preeclampsia history with the risk of early\u2010, intermediate\u2010 and late\u2010onset preeclampsia","volume":"178","author":"Boyd","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1111\/jth.13257_bb0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2014.10.114","article-title":"[108\u2010POS]: Assessment of concentrations of sFlt\u20101 and PlGF as predictors of preeclampsia","volume":"5","author":"Machado","year":"2015","journal-title":"Pregnancy Hypertens"},{"key":"10.1111\/jth.13257_bb0170","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00404-015-3671-8","article-title":"Diagnostic accuracy of the soluble Fms\u2010like tyrosine kinase\u20101\/placental growth factor ratio for preeclampsia: a meta\u2010analysis based on 20 studies","volume":"292","author":"Liu","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"10.1111\/jth.13257_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1600-0897.2011.01007.x","article-title":"Modulation of trophoblast angiogenic factor secretion by antiphospholipid antibodies is not reversed by heparin","volume":"66","author":"Carroll","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/jth.13257_bb0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.120084","article-title":"Utility of antiphosphatidylserine\/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus","volume":"40","author":"Akhter","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1111\/jth.13257_bb0185","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/ard.2004.031856","article-title":"Real world experience with antiphospholipid antibody tests: how stable are results over time?","volume":"64","author":"Erkan","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.13257_bb0190","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low\u2010molecular\u2010weight heparin versus low\u2010dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13257","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13257","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622046359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622046359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13257\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:16:19Z","timestamp":1761534979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622046359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1538783622046359"],"URL":"https:\/\/doi.org\/10.1111\/jth.13257","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies and the risk of severe and non\u2010severe pre\u2010eclampsia: the NOHA case\u2010control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}